MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Interest
MEDICAL DEVELOPMENTS ORDINARY (ASX:MVP) had 0.00% of shares reported as short positions as of 16 July 2026, representing 152 shares. MEDICAL DEVELOPMENTS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Medical Developments International
Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4MVP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Medical Developments International
Latest MVP news
All news- Medical tech firm Ceretas fast tracks IPO to fund clinical trials
afr
- Imricor Medical Shares Surge on Fresh FDA Clearance
kalkine
- Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today - Kalkine
googlenews
- Imricor Medical Systems Gains FDA Paediatric Clearances for NorthStar and Diagnostic Catheter
smallcaps
- AI Stocks To Watch With Real Exposure To Chips Software And Medical AI - simplywall.st
googlenews
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss MVP
Start a research thread or post the first pulse update